Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry

被引：0

作者：

M E Work

E M John

I L Andrulis

J A Knight

Y Liao

A M Mulligan

M C Southey

G G Giles

G S Dite

C Apicella

H Hibshoosh

J L Hopper

M B Terry

机构：

[1] Mailman School of Public Health,Department of Epidemiology

[2] Columbia University,Division of Epidemiology, Department of Health Research and Policy

[3] Cancer Prevention Institute of California,Department of Molecular Genetics

[4] and Stanford Cancer Institute,Division of Epidemiology

[5] Stanford University School of Medicine,Department of Laboratory Medicine and Pathobiology

[6] Samuel Lunenfeld Research Institute,Department of Pathology

[7] Mount Sinai Hospital,Department of Epidemiology and Institute of Health and Environment

[8] University of Toronto,undefined

[9] Dalla Lana School of Public Health,undefined

[10] University of Toronto,undefined

[11] Laboratory Medicine Program,undefined

[12] University Health Network,undefined

[13] University of Toronto,undefined

[14] The University of Melbourne,undefined

[15] Cancer Epidemiology Centre,undefined

[16] Cancer Council Victoria,undefined

[17] Centre for Molecular,undefined

[18] Environmental,undefined

[19] Genetic and Analytic Epidemiology,undefined

[20] University of Melbourne,undefined

[21] School of Public Health,undefined

[22] Herbert Irving Comprehensive Cancer Center,undefined

[23] Columbia University,undefined

来源：

British Journal of Cancer | 2014年 / 110卷

关键词：

breast cancer; epidemiology; breastfeeding; oral contraceptives;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1367 / 1377

页数：10

共 634 条

[1]

Althuis MD(2004)Etiology of hormone receptor-defined breast cancer: a systematic review of the literature Cancer Epidemiol Biomarkers Prev 13 1558-1568

[2]

Fergenbaum JH(2011)Incidence of breast cancer in the United States: current and future trends J Natl Cancer Inst 103 1397-1402

[3]

Garcia-Closas M(2011)Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study Am J Epidemiol 174 661-671

[4]

Brinton LA(2007)Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry Cancer 109 1721-1728

[5]

Madigan MP(2008)Recent trends in breast cancer among younger women in the United States J Natl Cancer Inst 100 1643-1648

[6]

Sherman ME(2002)Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age Am J Epidemiol 156 507-516

[7]

Anderson WF(2006)Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2492-2502

[8]

Katki HA(2012)Age-specific incidence of breast cancer subtypes: understanding the black-white crossover J Natl Cancer Inst 104 1094-1101

[9]

Rosenberg PS(2004)Risk factors for breast cancer according to estrogen and progesterone receptor status J Natl Cancer Inst 96 218-228

[10]

Bao PP(1996)Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies Lancet 347 1713-1727

← 1 2 3 4 5 6 7 8 9 10 →